Related references
Note: Only part of the references are listed.Ankylosing Spondylitis Disease Activity Score (ASDAS): 2018 update of the nomenclature for disease activity states
Pedro M. Machado et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Clinical and MRI remission in patients with nonradiographic axial spondyloarthritis who received long-term open-label adalimumab treatment: 3-year results of the ABILITY-1 trial
Desiree van der Heijde et al.
ARTHRITIS RESEARCH & THERAPY (2018)
Non-radiographic axial spondyloarthritis patients without initial evidence of inflammation may develop objective inflammation over time
Xenofon Baraliakos et al.
RHEUMATOLOGY (2017)
Sustained efficacy, safety and patient-reported outcomes of certolizumab pegol in axial spondyloarthritis: 4-year outcomes from RAPID-axSpA
Desiree van der Heijde et al.
RHEUMATOLOGY (2017)
2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis
Desiree van der Heijde et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Clinical and MRI responses to etanercept in early non-radiographic axial spondyloarthritis: 48-week results from the EMBARK study
Walter P. Maksymowych et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
A Randomized, Double-Blind, Placebo-Controlled, Sixteen-Week Study of Subcutaneous Golimumab in Patients With Active Nonradiographic Axial Spondyloarthritis
J. Sieper et al.
ARTHRITIS & RHEUMATOLOGY (2015)
Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force
Josef S. Smolen et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
The Assessment of SpondyloArthritis international Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general
M. Rudwaleit et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis
D. van der Heijde et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Development and preselection of criteria for short term improvement after anti-TNFα treatment in ankylosing spondylitis
J Brandt et al.
ANNALS OF THE RHEUMATIC DISEASES (2004)
Share Paper
